Chiche, L Y <br/><br/>
[Thirteen reasons why B cell may not be the best therapeutic target in systemic lupus erythematosus].  [electronic resource] 

 -  La Revue de medecine interne  04 2019 
 - 207-210 p.  digital 
<br/><br/> Publication Type: Editorial 
<br/><br/><label>ISSN: </label>1768-3122 
<br/><br/><label>Standard No.: </label>10.1016/j.revmed.2018.05.005  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal, Humanized--adverse effects<br/>B-Lymphocytes--physiology<br/>Drug-Related Side Effects and Adverse Reactions--epidemiology<br/>Humans<br/>Immunotherapy--adverse effects<br/>Lupus Erythematosus, Systemic--epidemiology<br/>Molecular Targeted Therapy--adverse effects<br/>Rituximab--adverse effects<br/>Treatment Failure